Rommelag and Toxikon Europe announce strategic partnership to support the pharmaceutical industry

Waiblingen, Germany and Leuven, Belgium: – Rommelag and Toxikon Europe announce their strategic partnership, leveraging their collective extensive knowledge and expertise in the engineering, development, contract manufacturing and pharmaceutical testing of bottelpack Blow-Fill-Seal container/closure system applications for wide variety of pharmaceutical dosage forms. With this partnership, the partners offer a range of unsurpassed technical and scientific services. This will allow the Rommelag Group to support their pharmaceutical and biopharmaceutical customers with an in-depth qualification and acceptance process for Rommelag’s Blow-Fill-Seal packaging solutions, across the globe. The support given by Toxikon Europe through this agreement relates to the extractables and leachables testing, toxicological assessments, impurity identifications and biocompatibility testing for the Blow-Fill-Seal systems, offered by the Rommelag Group.

Ralf Bouffleur, Executive Vice-President, Rommelag Group

“This partnership is yet another important element of our intention to provide a complete package of world class Blow-Fill-Seal applications. We are convinced that with Toxikon’s top level analytical services we are able to provide essential added value to our customers. Project times will be shortened, communication will be easier and services will be based on an unsurpassed experience level. We have been working together successfully for quite some time, now we will take it to the next level. Therefore, we are proud to cooperate with Toxikon’s motivated team in order to fulfil our mission: to make our customers successful.”

Piet Christiaens, Scientific Director, Toxikon Europe NV

“We are extremely pleased with this partnership with Rommelag, as it formalizes the existing intense, multiyear collaboration between the two companies. However, by taking this next step in this cooperation, it allows both Toxikon Europe and Rommelag to further intensify the integration of their qualification services and to enhance the role of Rommelag as a “total solution provider” when it comes to a testing and qualifying bottelpack aseptic Blow-Fill-Seal packaging solutions for the Pharma and Biopharma Industry. With our state-of-the-art instrumentation, the profound expertise and the optimized protocols in qualifying Blow-Fill-Seal applications from an Extractables & Leachables point of view, I am absolutely convinced that Toxikon Europe can play a vital role rapid and compliant qualification and acceptance process for the Blow-Fill-Seal systems by the pharmaceutical and biotech industry.”

About Rommelag

With its four specialist divisions of ENGINEERING, CMO, FLEX, and SERVICE, the Rommelag brand represents a strong network of local, independent companies across Germany and Switzerland that each share the same end goal: reaffirming to you on each and every project that choosing Rommelag was the best decision you ever made.

Rommelag ENGINEERING is the inventor of blow-fill-seal technology (BFS) and the global market leader in the aseptic filling of liquids and semisolids with its bottelpack machines that are primarily used in the pharmaceutical, chemical, and food industries.

Rommelag CMO provides quick and easy access to BFS technology without having to invest in either the mandatory GMP environment that goes with it or the specialists required to operate and maintain the machines.

Rommelag FLEX offers special containment solutions for bulk goods and film-based packaging
solutions.

Rommelag SERVICE are the specialists for commissioning, validating, repairing, or servicing bottelpack systems before issues arise.

About Toxikon Europe NV

Toxikon Europe is an independent, privately owned Contract Research Organisation, specialized in providing premium Extractable & Leachable Services to the Pharmaceutical Industry. Based in Belgium, Toxikon Europe supports Pharma Companies – across the Globe – in developing worldwide compliant (FDA, EMA) Testing Strategies to qualify Container/Closure Applications and Pharmaceutical Production Equipment from an Extractable & Leachable Perspective. In addition, the Toxikon group also provides Biocompatibility Testing Services (In-Vivo and In-Vitro testing) to both the Medical Device and the Pharmaceutical Industries.

Toxikon is ISO 17025 Accredited, GLP-Certified and GMP Accredited. Toxikon is also FDA registered.